Rockwell Medical (RMTI) Free Cash Flow (2010 - 2026)
Rockwell Medical (RMTI) posted Free Cash Flow of -$625000.0 for Q1 2026, down 128.88% on a QoQ basis from $2.2 million in Q4 2025, and up 82.39% year-over-year from -$342664.1 in Q1 2025.
Rockwell Medical (RMTI) Free Cash Flow (2010 - 2026) Analysis & Trends
Rockwell Medical's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$625000.0 for Q1 2026.
- Quarterly Free Cash Flow rose 82.39% year-over-year to -$625000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 million (down 22.08% YoY) and the FY2025 annual result came in at -$1.2 million, down 138.92% from the prior year.
- Free Cash Flow was -$625000.0 for Q1 2026 at Rockwell Medical, down from $2.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $4.1 million in Q3 2024 and bottomed at -$9.8 million in Q1 2022.
- A 5-year average of -$1.5 million and a median of -$1.0 million in 2022 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow sank 268.79% — and 2024, when it soared 646.51%.
- Rockwell Medical's Free Cash Flow stood at -$393000.0 in 2022, then soared by 78.12% to -$86000.0 in 2023, then surged by 646.51% to $470000.0 in 2024, then surged by 360.43% to $2.2 million in 2025, then sank by 128.88% to -$625000.0 in 2026.
- Business Quant data shows RMTI's Free Cash Flow at -$625000.0 in Q1 2026, $2.2 million in Q4 2025, and -$1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | -625,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -625,000.00 |
| Mar 31, 2026 | -625,000.00 |
| Dec 31, 2025 | 2.16 Mn |
| Dec 31, 2025 | 2.16 Mn |
| Sep 30, 2025 | -1.58 Mn |
| Sep 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | -3.55 Mn |
| Mar 31, 2025 | -3.55 Mn |
| Dec 31, 2024 | 470,000.00 |
| Dec 31, 2024 | 470,000.00 |
| Sep 30, 2024 | 4.08 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Jun 30, 2024 | 1.16 Mn |
| Mar 31, 2024 | -2.52 Mn |
| Mar 31, 2024 | -2.52 Mn |
| Dec 31, 2023 | -86,000.00 |
| Dec 31, 2023 | -86,000.00 |